Use Of Jasmonate Ester Derivatives For Treating Benign Hyperproliferative Skin Disorders

Abstract

The present invention relates to methods of treating benign hyperproliferative diseases of the epidermis by administering a composition comprising at least one jasmonate ester derivative. In particular, the present invention provides jasmonate ester derivatives as potent compounds useful for the treatment of disorders such as actinic keratoses with reduced side effects.


Claims
Download PDF
Document Preview
Document History
  • Publication: Mar 15, 2016
  • Application: Sep 25, 2014
    US US 201414497020 A
  • Priority: Sep 25, 2014
    US US 201414497020 A
  • Priority: Dec 8, 2011
    US US 201113376917 A
  • Priority: Jun 3, 2010
    IL IL 2010000438 W
  • Priority: Oct 7, 2009
    US US 24926509 P
  • Priority: Jun 9, 2009
    US US 18522109 P

Download Citation


Sign in to the Lens

Feedback